Skip to main content
  •  
  • NRG Apps
  • News
  • Login
NRG Oncology
  • Patients
    • Patients Overview
    • Patient Study Materials
    • Patient Advocate Committee
  • Our Research
    • red icon of a clipboard with a medical + on it Clinical Trials
    • red icon of a book Research Resources
      • Research Resources Overview
      • Ancillary Projects & Data Sharing
      • Biospecimen Access
      • Data Management Resources
      • DMC Charters and Minutes
      • Investigator Resources
      • Quality Assurance (QA) Resources
      • Statistical Reports
    • red icon of a person reading a book or magazine Publications & Presentation Resources
  • Committees
    • Leadership & Committee Openings
    • red icon of a book Oversight Committees
      • Oversight Committees Overview
      • Data Monitoring Committee
      • Early Phase Trial Oversight Committee
      • Executive Committee
      • Protocol Operations Management
      • Research Strategy
    • Disease Specific Committees
      • Disease Specific Committees Overview
      • Brain Tumor
      • Breast Cancer
      • Gastrointestinal Cancer
      • Genitourinary Cancer
      • Gynecologic Cancer
        • Gynecologic Cancer Overview
        • Cervix/Vulva Cancer Subcommittee
        • Ovarian Cancer Subcommittee
        • Rare Tumor Subcommittee
        • Uterine Corpus Cancer Subcommittee
      • Head and Neck Cancer
      • Lung Cancer
    • red icon of a person reading a book or magazine NCORP Committees
      • NCORP Committees Overview
      • Cancer Care Delivery Research
      • Cancer Prevention & Control
      • Health Care Access
      • Patient Centered Outcomes Research
    • red icon of a person reading a book or magazine Non-Disease Specific Committees
      • Non-Disease Specific Committees Overview
      • Cancer Care Delivery Research
      • Cancer Prevention & Control
      • Developmental Therapeutics (DT)
        • Developmental Therapeutics (DT) Overview
        • DT Radiation Therapy Subcommittee
        • DT Gynecologic Phase I Subcommittee
        • Sarcoma Subcommittee
      • Patient Centered Outcomes Research
      • Translational Science
    • Scientific Core Committees
      • Scientific Core Committees Overview
      • Health Care Access (HCA)
        • Health Care Access (HCA) Overview
        • HCA Committee Events & Announcements
      • Imaging
        • Imaging Overview
        • Theranostics Subcommittee
      • Medical Oncology
        • Medical Oncology Overview
        • Immunotherapy Subcommittee
        • Pharmacy Subcommittee
      • Pathology
      • Protocol Support
        • Protocol Support Overview
        • CRA Subcommittee
        • CTN Subcommittee
        • Education & Training Subcommittee
        • Mentorship Subcommittee
        • Protocol Review Subcommittee
        • Quality Control & Communication Subcommittee
      • Radiation Oncology
        • Radiation Oncology Overview
        • Medical Physics Subcommittee
        • Theranostics Subcommittee
      • Surgical Oncology
    • Administrative Committees
      • Administrative Committees Overview
      • Ancillary Projects
      • Communications
      • Investigator & Career Development
        • Investigator & Career Development Overview
        • Early Career Mentorship Subcommittee
        • Investigator Development Subcommittee
      • Membership
        • Membership Overview
        • Canadian Members Subcommittee
        • International Members Subcommittee
        • Veteran Affairs/Military Treatment Facility Subcommittee
      • Patient Advocate Committee
      • Publications
  • About Us
    • red icon of a clipboard with a medical + on it What is NRG Oncology
      • What is NRG Oncology Overview
      • Scientific Focus
      • Legacy Groups
      • Support NRG
      • Contact Us
    • red icon of a book Policies and Bylaws
    • Organizational Overview
      • Organizational Overview
      • Organizational Structure
      • Operations
      • SDMC
      • NCORP (Overview & PIs)
      • Biospecimen Bank
      • Translational Science
      • CIRO
    • Membership
      • Membership Overview
      • Member Information Form
      • Membership Requirements
      • Membership Applications & Roster Forms
      • Membership Committee Reviews
      • Member Institution Lists
    • Education & Training
      • Education & Training Overview
      • CLASS Learning Modules
      • Credentialing & Other Resources
      • VisionTree Training
    • red icon of a person reading a book or magazine Mentorship Programs
      • Mentorship Programs Overview
      • Health Care Access Fellowship
      • Early Career Mentored Fellowship Program
      • Clinical Research Coordinator Mentor Program
    • red icon of a book Media & News
      • Media & News Overview
      • Newsletters
      • The NRG Oncology Podcast
      • Weekly Broadcasts
  • Meetings
    • Meetings Overview
    • NRG Oncology 2026 Winter Meeting
    • Past NRG Meetings (past two years)
    • Future NRG Meetings
    • NRG Meeting Attendee Policies
    • Major Scientific Meetings
Login
NRG Apps
Admin Portal
News
  • NRG Apps
  • News
  • Login
NRG Oncology
  • Patients

    • Patients Overview
    • Patient Study Materials
    • Patient Advocate Committee
  • Our Research

    Our Research

    See our clinical trial portfolio as well as other areas of research conducted by NRG and our publication process.

    Our Research Overview
    • red icon of a clipboard with a medical + on it Clinical Trials
    • red icon of a book Research Resources
    • red icon of a person reading a book or magazine Publications & Presentation Resources
    woman sitting at a desk, hands on keyboard. there is a man behind her, also at a desk. there is are large windows behind them

    The NRG Summer 2025 Semiannual Meeting will be held in person at the Marriott Marquis Hotel in Washington, D.C., from July 24, 2025 – July 26, 2025.

    Explore Resources
    two men sitting and talking, one appears to be a doctor, in a lab coat. the doctor has his hand on the man's shoulder

    Search through all available NRG Oncology protocols and available materials.

    Find Trials
    • Research Resources Overview

      A compilation of all resources relevant to research conduct or reporting.

    • Ancillary Projects & Data Sharing

      Resources, contact information, applications, and review cycles for ancillary projects and data sharing.

    • Biospecimen Access

      How to request biospecimens collected from patients enrolled on NRG trials (and legacy groups GOG, NSABP, and RTOG).

    • Data Management Resources

      Data Management contact list, compiled resources for sites, and PRO resources.

    • DMC Charters and Minutes

      Data Monitoring Committee (DMC) Panels A, B, and C minutes are password protected (CTEP IAM/ID.me login).

    • Investigator Resources

      Investigator-specific resources or tools to aid in clinical trial participation or conduct.

    • Quality Assurance (QA) Resources

      Information and additional links to resources for NRG’s audit program.

    • Statistical Reports

      NRG trial statistical reports shared at NRG Semiannual Meetings.

    room with rows of chairs, filled with people. there is a speaker at the front on a stage

    Are you presenting on behalf of NRG Oncology? We have templates for presentations and posters for our research here.

    Find a Template
  • Committees

    Committees

    Our committees are a network of professionals with varying experience that come together to advance NRG’s research.

    Committees Overview
    • Leadership & Committee Openings
    • red icon of a book Oversight Committees
    • Disease Specific Committees
    • red icon of a person reading a book or magazine NCORP Committees
    • red icon of a person reading a book or magazine Non-Disease Specific Committees
    • Scientific Core Committees
    • Administrative Committees

    NRG Oncology is comprised of several committees and subcommittees that conduct or support NRG trials.

    Find a Committee
    Man standing at a podium and another man is next to him at a table, talking into a mic

    Check and apply to open membership or leadership positions within our organization.

    Check Openings
    • Oversight Committees Overview

      Committees charged with guiding, reviewing, evaluating, and implementing clinical trials in alignment with the NCTN.

    • Data Monitoring Committee

      Reviews the efficacy and morbidity data of trials to ensure decisions regarding these studies are ethically responsible.

    • Early Phase Trial Oversight Committee

      Oversees the group’s Phase I and non-randomized Phase II trials for safety and lead-in components of protocols.

    • Executive Committee

      Comprised of NRG leadership roles and tasked with setting priorities for the group.

    • Protocol Operations Management

      Monitors the progress of activated studies and assesses trial accrual as well as other trial performance metrics.

    • Research Strategy

      Focused on study development and providing feedback or recommendations to disease site and scientific core committees.

    • Disease Specific Committees Overview

      Comprised of 7 committees dedicated to the disease sites most commonly represented in NRG research.

    • Brain Tumor

      Focused on brain tumor research including primary and secondary tumors of the central nervous system.

    • Breast Cancer

      Focused on research aimed at improving the management and outcomes of breast cancer.

    • Gastrointestinal Cancer

      Comprised of colorectal and non-colorectal cancer sectors focused on reducing the burden of GI malignancies for patients.

    • Genitourinary Cancer

      Focused on improving outcomes in GU cancers including prostate, kidney. Bladder, & testicular cancers.

    • Gynecologic Cancer

      Oversees all gynecologic subcommittee cancer research efforts including clinical trial design and translational research.

    • Head and Neck Cancer

      Focused on research aimed at improving the management and outcomes of head & neck cancer.

    • Lung Cancer

      Focused on improving survival and quality of life for patients with non-metastatic lung cancer.

    • NCORP Committees Overview

      NRG NCORP includes committees that improve delivery, disease prevention & control, access & patient quality-of-life.

    • Cancer Care Delivery Research

      Improves clinical outcomes & patient well-being by minimizing factors that may influence care delivery.

    • Cancer Prevention & Control

      Prioritizes interventional studies to improve symptom burden or prevent cancer morbidity.

    • Health Care Access

      Assesses & eliminates differences in health care access to improve cancer care and outcomes.

    • Patient Centered Outcomes Research

      Assesses patient-reported outcomes in therapeutic and cancer control trials.

    • Non-Disease Specific Committees Overview

      Consists of four committees that conduct NRG trials and support research within the disease site committees.

    • Cancer Care Delivery Research

      Improves clinical outcomes & patient well-being by minimizing factors that may influence care delivery.

    • Cancer Prevention & Control

      Prioritizes interventional studies to improve symptom burden or prevent cancer morbidity.

    • Developmental Therapeutics (DT)

      Identifies dose, schedule & preliminary efficacy of novel therapeutic approaches on Phase I & II trials.

    • Patient Centered Outcomes Research

      Assesses patient-reported outcomes in therapeutic and cancer control trials.

    • Translational Science

      Provides translational science expertise to NRG trials & education on new technologies.

    • Scientific Core Committees Overview

      Consists of seven committees that serve as shared resources of expertise and technology for conducting our trials.

    • Health Care Access (HCA)

      Assesses & eliminates differences in health care access to improve cancer care and outcomes.

    • Imaging

      Charged with enhancing the use of imaging on NRG trials and evaluating new novel imaging for trials.

    • Medical Oncology

      Supports systemic treatments used in NRG trials.

    • Pathology

      Assists with the pathology components across disease sites on NRG trials.

    • Protocol Support

      Responsible for overseeing support and quality control of protocol-related activities.

    • Radiation Oncology

      Coordinates NRG’s radiation oncology-related activities for trials.

    • Surgical Oncology

      Focused on providing expertise on NRG trials that require surgical components in treatment.

    • Administrative Committees Overview

      Committees that manage efforts to build engagement, reach, & result reporting for clinical trials & information.

    • Ancillary Projects

      Responsible for the review & conduct of ancillary projects utilizing NRG data.

    • Communications

      Responsible for developing and disseminating content to members & the public regarding NRG trials & efforts.

    • Investigator & Career Development

      Focused on fostering investigator growth and engagement in NRG.

    • Membership

      Responsible for maintaining the process for which NRG members are accepted & operating within the group.

    • Patient Advocate Committee

      Advocates (patients/ caregivers) who partner with our researchers and liaison to their communities regarding research.

    • Publications

      Focused on releasing NRG results in a timely manner via journal publications, presentations, & more.

    • Gynecologic Cancer Overview

      Oversees all gynecologic subcommittee cancer research efforts including clinical trial design and translational research.

    • Cervix/Vulva Cancer Subcommittee

      Part of the GYN cancer committee umbrella. Focused on research pertaining to the cervix or vulva.

    • Ovarian Cancer Subcommittee

      Part of the GYN cancer committee umbrella. Focused on research pertaining to the ovaries.

    • Rare Tumor Subcommittee

      Part of the GYN cancer committee umbrella. Focused on rare cancer types & their biomolecular/genetic abnormalities.

    • Uterine Corpus Cancer Subcommittee

      Part of the GYN cancer committee umbrella. Focused on research pertaining to uterine malignancies.

    • Developmental Therapeutics (DT) Overview

      Identifies dose, schedule & preliminary efficacy of novel therapeutic approaches on Phase I & II trials.

    • DT Radiation Therapy Subcommittee

      Focuses on safety and efficacy of radiotherapy treatments in Phase I & II trials.

    • DT Gynecologic Phase I Subcommittee

      Focuses on safety and efficacy of therapeutics specific to Phase I gynecologic cancers.

    • Sarcoma Subcommittee

      Focuses on research pertaining to or correlating with sarcoma cancers.

    • Health Care Access (HCA) Overview

      Assesses & eliminates differences in health care access to improve cancer care and outcomes.

    • HCA Committee Events & Announcements

      HCA has several events, workshops, symposia & more to with varying topics and learning opportunities.

    • Imaging Overview

      Charged with enhancing the use of imaging on NRG trials and evaluating new novel imaging for trials.

    • Theranostics Subcommittee

      A collaboration of the Imaging & Radiation Oncology Committees for trials that include theranostics.

    • Medical Oncology Overview

      Supports systemic treatments used in NRG trials.

    • Immunotherapy Subcommittee

      Evaluates NRG concepts that utilize immunotherapy.

    • Pharmacy Subcommittee

      Supports NRG trials with pharmacy-specific input including drug information & toxicity management.

    • Protocol Support Overview

      Responsible for overseeing support and quality control of protocol-related activities.

    • CRA Subcommittee

      Advisory subcommittee helping facilitate the goals of the PSC specific to clinical research associates.

    • CTN Subcommittee

      Advisory subcommittee helping facilitate the goals of the PSC specific to clinical trial nurses.

    • Education & Training Subcommittee

      Develops educational programs for CRAs and CTNs in attendance at the NRG Meetings.

    • Mentorship Subcommittee

      Develops and refunds that CRA/CTN Mentorship Program.

    • Protocol Review Subcommittee

      Prospectively reviews protocols & major amendments for barriers & compliance.

    • Quality Control & Communication Subcommittee

      Identifies common audit issues, resolves data issues & distributes content through NRG Communications.

    • Radiation Oncology Overview

      Coordinates NRG’s radiation oncology-related activities for trials.

    • Medical Physics Subcommittee

      Composed of physicists with expertise in the development of technology employed in radiation therapy.

    • Theranostics Subcommittee

      A collaboration of the Imaging & Radiation Oncology Committees for trials that include theranostics.

    • Investigator & Career Development Overview

      Focused on fostering investigator growth and engagement in NRG.

    • Early Career Mentorship Subcommittee

      Committed to the inclusion of early-career investigators through the protocol development process.

    • Investigator Development Subcommittee

      Focused on expanding opportunities & engagement for investigators at all career levels.

    • Membership Overview

      Responsible for maintaining the process for which NRG members are accepted & operating within the group.

    • Canadian Members Subcommittee

      Focused specifically on the accrual & research aims for Canadian sites.

    • International Members Subcommittee

      Focused on accrual & research aims for international institutions.

    • Veteran Affairs/Military Treatment Facility Subcommittee

      Addresses research aims & obstacles specific to veteran and military treatment facilities.

  • About Us

    About Us

    NRG conducts multi-institutional phase II & III clinical trials as well as phase I & translational biological studies.

    About Us Overview
    • red icon of a clipboard with a medical + on it What is NRG Oncology
    • red icon of a book Policies and Bylaws
    • Organizational Overview
    • Membership
    • Education & Training
    • red icon of a person reading a book or magazine Mentorship Programs
    • red icon of a book Media & News
    woman standing at a mic with rows of tables next to and behind her with people sitting at them

    Make your voice heard. Join NRG and help us move the needle in cancer research.

    Register Here
    • What is NRG Oncology Overview

      Learn more about who we are and what our overarching organizational goals are as an NCI NCTN group.

    • Scientific Focus

      NRG has several scientific aims through our research. Learn more in our scientific focus section.

    • Legacy Groups

      NRG is comprised of three legacy groups. Learn more about our history & the three Foundations.

    • Support NRG

      Learn how you can be a part of our mission to improve outcomes for all impacted by cancer.

    • Contact Us

      Fill out our contact form or find specific contact information by department.

    Policies, guidelines, bylaws, and charters pertaining to our organization & research.

    View All
    • Organizational Overview

      This overview leads into the many sections and centers that work together under NRG to improve cancer outcomes.

    • Organizational Structure

      See the organizational charts the outline the multiple sections that keep NRG research moving forward.

    • Operations

      These offices help streamline the administrative and protocol development areas of our trials from start to finish.

    • SDMC

      The Statistics and Data Management Center provide expertise for design, conduct, and analysis of NRG trials.

    • NCORP (Overview & PIs)

      NRG’s NCI Community Oncology Research Program brings cancer trials to the community.

    • Biospecimen Bank

      NRG has Biospecimen Banks located in Columbus, Pittsburgh, and San Francisco. Learn more here.

    • Translational Science

      NRG’s translational science program intersects with all NRG clinical trial as well as ancillary projects.

    • CIRO

      The Center for Innovation in Radiation Oncology houses contouring atlases, templates, & tools to conduct research.

    • Membership Overview

      Includes Membership information, related documents or forms, requirements, and other applicable items.

    • Member Information Form

      All members are required to participate in our membership database form even if the response is opting out.

    • Membership Requirements

      Outline of membership categories including associated requirements & responsibilities.

    • Membership Applications & Roster Forms

      Information on how to apply for membership, make changes to your roster & who to contact for questions.

    • Membership Committee Reviews

      This password-protected area includes the content reviewed during Membership Committee meetings twice a year.

    • Member Institution Lists

      All available lists of member sites by type of member, location, CTEP ID, & voting members.

    • Education & Training Overview

      NRG offers educational materials and training courses for a variety of topics relevant to the conduct of our research.

    • CLASS Learning Modules

      Compliance, Learning, and SOP Solutions (CLASS) platform is a learning management system supported by CTSU.

    • Credentialing & Other Resources

      Contact information for RT & Imaging credentialing plus links to other important credentialing or trial resources.

    • VisionTree Training

      VisionTree platform, used on some NRG trials, hosts an NRG-VisionTree training webinar once a month.

    • Mentorship Programs Overview

      NRG is committed to the future of cancer research in all areas and levels of expertise through our mentorship programs.

    • Health Care Access Fellowship

      Health Care Access Fellowship

    • Early Career Mentored Fellowship Program

      NRG selects early-stage investigators via application process to be part of a mentored experience in trial development.

    • Clinical Research Coordinator Mentor Program

      Learn more about our CRC mentorship program and how to become a mentor or mentee.

    • Media & News Overview

      NRG has multiple sources of news including podcasts, newsletters, email broadcasts, and more.

    • Newsletters

      Archive of all NRG Currents newsletter editions. Each edition discusses a wide range of topics.

    • The NRG Oncology Podcast

      The NRG Oncology Podcast is an ongoing streaming podcast with new episodes each month.

    • Weekly Broadcasts

      NRG releases a weekly broadcast each Monday with all important updates on studies and other news.

  • Meetings

    • Meetings Overview
    • NRG Oncology 2026 Winter Meeting
    • Past NRG Meetings (past two years)
    • Future NRG Meetings
    • NRG Meeting Attendee Policies
    • Major Scientific Meetings

PSC Column: Cancer: DTL Overview

09/12/2024

Written by Belinda Buehl, Regulatory Coordinator, University of Wisconsin Hospital and Clinics, Department of Human Oncology -Radiation Oncology

The DTL or Delegation of Tasks Log application within the CTSU is utilized to document the delegation of tasks for the study team. The site-level Clinical Investigator or CI delegates the tasks to the appropriately trained team members at the site for individual studies. Delegated tasks can vary per protocol. Signed/approved DTLs are required to obtain site registration approval. Without a signed DTL, sites cannot enroll subjects via the Oncology Patient Enrollment Network (OPEN).

DTLs are utilized to ensure site CIs delegate appropriate study related tasks to study team members, improve the ability to track study-specific training for study team members, ensure tasks are delegated prior to study enrollment, and to provide a complete list and history of study team members who contribute to the clinical data for each study. The DTL application interfaces with the Regulatory Support System (RSS), OPEN, and Medidata Rave.

A quick overview of the DTL process is as follows: The LPO (Lead Protocol Organization) creates and maintains the DTL templates. Clinical site staff are assigned access depending on their role to view, create, maintain and approve the study site DTLs.

It is very important for study integrity for the DTLs to be properly maintained. This has been a challenge for clinical sites and has been noted to be a recurring finding during the auditing process by the NRG Oncology Audit team. A major deficiency may be found at the time of audit if study-related tasks are performed by staff who are not on the DTL, performing tasks not assigned to the individual, for allowing the annual renewal to lapse, or if tasks are performed while a DTL is not approved.

The most common deficiencies are approval/renewal gaps and or missing approvals, and inactive DTLs.

Approval/Renewal Gaps and Missing approvals:

DTLs must be signed by the CI and approved prior to site registration approval for newly activated studies.Sites have 60 days to complete DTLs in order to have an approved registration status for studies where the DTL was released after activation or if an updated version of a DTL is available. DTLs need to be approved prior to the performance of any study related activities.

Expired DTLs are a common finding during the audit process. CIs are required to re-sign DTLs by the one year anniversary of the last signing. Reminders should be sent out automatically at 30 days, 14 days and 1 day prior to the renewal date.

Automatic system notifications regarding approvals and renewals are sent to the CI and DTLA (DTL Administrator) for the specific DTL when there is a DTL is ready for approval, but there can be problems receiving the notifications. The notifications are sent to the email address on file within the Registration Credential Repository (RCR) system.If that email is incorrect the notifications will not be received. Another helpful tip is to ensure CIs know to check the spam folder. Unfortunately, automatic notifications are commonly routed to the spam folder, so it is important to encourage CIs to regularly check for email notificationsDTLAs can also generate emails outside of the automatic system notifications to remind CIs to sign or renew DTLs.

Blank DTLs

With the newest update to the DTL application – it has been noted by auditors that the DTL will appear blank if it has not been signed. This can be a problem because on the initiator side, it may appear that the DTL is filled out, but many sites mistakenly think that as long as the DTL is filled out with tasks listed, then they can begin to perform study related activities. This is not the case, the tasks must be assigned and approved by the CI before initiating any study related activities. If the auditor is trying to review the DTL and it is not signed, it could appear blank to them, and it would seem like no tasks have been assigned or approved. Performing tasks without an approved DTL is a major deficiency.

Inactivated DTLs

If the RCR registration is suspended for anyone on the DTL, an end date will show up and the DTL will change to unapproved, and the status will be set to Pending.In this case, the study team member with the expired RCR will need to be removed and then reactivated once they have renewed their RCR. This can cause a problem during an audit if it is not known that an RCR has expired. If the DTL is set to pending it needs to be re-signed and reactivated by the CI in order to be accepted, major deficiencies can occur if the status has reverted back to pending.

A good tip for sites who struggle with any of these findings would be to create a DTL tracker internally that is checked at minimum monthly. When it is 30 days prior to renewal for a DTL it can be helpful to add reminders in a personal calendar or set up auto-reminders. DTLAs, or other assigned team members can personally email the CIs to ensure they are aware ahead of time when a renewal is required. This way sites can plan around possible time off and hopefully ensure the DTLs are renewed timely. Smartsheets are a great option for creating internal trackers for sites. Smartsheets can be personalized to fit the site and can be shared so multiple team members have the ability to update the trackerAnother great resource to troubleshoot common issues with DTLs is on the CTSU website – A Compiled DTL Site Guide is available with many useful topics to assist with the maintenance of DTLs.

Hopefully this overview of the importance of DTLs and discussion of common findings will be helpful to encourage sites to create personalized trackers to help avoid findings at future audits.

Back

News

Home All News
  • NRG Newsletters
    • 2024 Newsletters
    • 2023 Newsletters
  • Weekly Broadcasts
    • 2024 Weekly Broadcast Archive
    • 2025 Weekly Broadcast Archive

Stay current with science. Sign up for our newsletter.

grey diamond icon

Support NRG Oncology.
Help Our Cause.

We are a leading protocol organizations within the National Clinical Trials Network and we seek to improve the lives of cancer patients by conducting practice-changing, multi-institutional clinical and translational research. Learn More

Donate Today

  • $25
  • $50
  • $75
  • $100
  • Other

NRG Oncology Foundation, Inc, is a nonprofit, tax-exempt foundation. Donations to NRG Oncology help us conduct this important mission, and are tax-deductible to the extent permitted by law.

NRG logo
Four Penn Center,
1600 JFK Blvd, Suite 1020,
Philadelphia, PA 19103

Phone: 267-519-6630

Fax: 215-854-0716

Email:
info@nrgoncology.org

Quick Links

  • News
  • NRG Oncology Meetings
  • Our Research
  • Support Our Mission

Membership

  • Membership Requirements
  • Membership Applications & Roster Forms
  • Member Institution Lists

Resources

  • Clinical Trial Search
  • The NRG Oncology Podcast
  • Presentation Templates & Slides
  • Policies & Bylaws
  • Education & Training

For Patients

  • Patient Study Materials
  • The NRG Oncology Patient Advocate Committee

About Us

  • Who We Are & What We Do
  • Statisics and Data Management Center (SDMC)
  • Biospecimen Banks
  • Center for Innovation in Radiation Oncology (CIRO)
  • NRG NCORP Research Base

© 2025 NRG Oncology